Is Omicron a Good Variant for Humankind?

Paul Collier November 29, 2021

It appears the much-vaunted Coronavirus variant emerging from South Africa, the Omicron variant, might be the kind of virus evolution we humans can get behind. The virus appears to have become more transmissible, but also less deadly, meaning the virus is increasing the chance it will become another yearly flu we might have to deal with and little more.

The power to shut down and mandate might soon be coming to an end IF the early reports coming out of Africa are confirmed. One doctor is reporting that the symptoms are all mostly mild, especially compared to other variants. The WHO push to drive the world to fear might not have long legs as countries experience a much more mild, but more contagious version of the coronavirus. God willing, the early reports will be confirmed by what’s to follow.

The doctor who actually found the variant is the one sharing with the world the claim tha this variant is ‘extremely mild.’

Doctor Who Found Omicron Variant: ‘It’s Extremely Mild

From www.louderwithcrowder.com
2021-11-29 15:57:04
Joseph Gunderson
Excerpt:

Upon the discovery of a new variant of COVID-19, subsequently dubbed Omicron, the WHO has decided, in line with their particular brand of fear-mongering, that the variant “poses a very high risk of infection surges that could have ‘severe consequences’ in some places.”

“Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic… The overall global risk… is assessed as very high.”……..

“What we are seeing clinically in South Africa—and remember, I’m at the epicenter, that’s where I’m practicing—it’s extremely mild. We haven’t admitted anyone.”

Unlike so many ignorant lemmings who consume CNN brainwashing on a regular basis, I’m inclined to believe the doctors in the trenches far more than the bureaucrats in organizations like the WHO. And it doesn’t seem like Dr. Angelique Coetzee sounds too worried….

Dr Angelique Coetzee, the South African doctor who first spotted the new Covid variant Omicron, told #Marr the patients seen so far have had “very mild symptoms”

Read Full Article

3D-Printed Eardrums Restore Hearing to the Deaf

Parker Davis November 23, 2021

A team of Chinese scientists have developed a new type of 3D-printed ear drum that can either help heal an eardrum or replace it. They developed a Piezoelectric material, self-powered material, that allows the ear drum to function in the first place, as once it is implanted, you can’t readily remove it to replace the batteries.

As this is being developed by the CCP, no doubt whatever technological developments are happening here, sustaining reliance type folks should be working on open-sourced versions of this, and, more than likely, they already are.

Self-Powering Hearing Aids And 3D Printed Eardrums Help People Hear Again

From www.intelligentliving.co
2021-11-23 04:25:13

Excerpt:

Focusing on fixing a damaged cochlea, Yunming Wang and colleagues at China’s Huazhong University of Science and Technology developed a prototype implantable device that translates soundwaves into matching electrical signals when placed inside a model ear. Meanwhile, Harvard scientists focused on repairing a damaged eardrum and developed the PhonoGraft device, a 3D-printed, biocompatible graft implant to facilitate the healing process of eardrum perforations.

……….the scientists fabricated a material that used compression and friction, which are piezoelectric and triboelectric qualities. Piezoelectric materials are self-powered, becoming charged when compressed by the pressure that accompanies sound waves. Triboelectric materials produce friction and static electricity when moved by these sound waves. They used the new piezo-triboelectric spongey material to make a prototype acoustic sensing device that delivers high efficiency and sensitivity across a wide range of audio frequencies.

Read Full Article

A Top Fauci Lieutenant Refuses to Get Vaccine

Paul Collier November 9, 2021

Not ALL of the wanna-be science-kings menz wants to get the vaccines agains, or something like that. Humpty Fauci, as the story goes, has a problem on top of that wall of his, not all of the Fauci soldiers below that have continually helped put Humpty Fauci back together again are ready to stand by and collect the egg shells again.

One of his top scientists, Dr. Matthew Memoli, refuses to get the vaccine, contra to the king of science’s great declaration that to reject the Fauci is to reject the science. Well, Memoli is rejecting the science, which is problematic for Humpty Fauci, as you can now hopefully clearly see.

I love a good nursery rhyme but this one has no ryhme and it doesn’t help me at all fall asleep.

One Of Fauci’s Top Scientists Opposes Vaccine Mandates, Is Unvaccinated

From dailycaller.com
2021-11-08 18:33:22
Dylan Housman
Excerpt:

The National Institutes of Health (NIH) will hold a roundtable discussion on the ethics of vaccine mandates Dec. 1, and it will feature a scientist from Dr. Anthony Fauci’s agency making the case against forced vaccination for COVID-19.

Dr. Matthew Memoli runs a clinical studies unit at the National Institute of Allergy and Infectious Diseases (NIAID), the agency headed by Dr. Fauci, and will make the case against vaccine mandates at the NIH event, according to The Wall Street Journal. Memoli has said he supports COVID-19 vaccination in high-risk populations, such as for the elderly or obese, but emailed Fauci on July 30 to say that mandatory vaccination is “extraordinarily problematic.”

“There’s a lot of debate within the NIH about whether [a vaccine mandate] is appropriate,” said David Wendler, a senior NIH bioethicist. “It’s an important, hot topic.” https://t.co/MtQZseexkn

— Tim Hanrahan (@TimJHanrahan) November 8, 2021

All NIH employees…

Read Full Article

Is January the End of the Covid-19 Pandemic?

Freedomist Editor November 8, 2021

With both Pfizer and Merck now having released effective therapeutic treatment for Covid-19 that will render it significantly less than a threat than it is now, one Pfizer board member is predicting the end of the Covid-19 era come this January.

Pfizer Board Member Predicts COVID Pandemic Over in the U.S. by January

From feedproxy.google.com
2021-11-05 19:00:11
Leslie Eastman
Excerpt:

I find it fascinating that after the drubbing the COVID-restriction embracing Democrats received this week, a board member from one of the entities that have prospered during the pandemic is now willing to put a date on the end of the pandemic.

The Covid-19 pandemic could be over in the U.S. by the time President Biden’s workplace vaccine mandates take effect in early January, Pfizer board member Dr. Scott Gottlieb told CNBC’s “Squawk Box” Friday.

The vaccine requirements from the Occupational Safety and Health Administration take effect on Jan. 4 for any company with at least 100 employees. All affected workers must get either their second Moderna or Pfizer shot or one dose from Johnson & Johnson by that date or face regular testing for the virus.

“These mandates that are going to be put in place by Jan. 4 really are coming on the tail end of this pandemic,” said Gottlieb, who’s also a former commissioner of the Food and Drug Administration. “By Jan. 4,…

Read Full Article

Why People Who Had Covid-19 Might Not Need the Vaccines

Paul Collier November 4, 2021

There is a case to be made for many people, for various reasons, to consider not taking one of the Covid-19 vaccines currently being offered, or, unfortunately, in many cases, being made mandatory. For instance, the people who have already been infected with Covid-19 might be the ones least in need of getting the vaccine, next to, perhaps our children under the age of 13.

One study suggests that the effective memory of Covid-19 in people who have had the virus is 93 percent at 6 months, and 92 percent at one year/ This study offers more evidence that catching the virus is an effective immunization and therapeutic potency that matches or exceeding vaccination levels perhaps for longer periods of times without additional risk to the person or to anyone else around them.

From doctorsandscientistsdeclaration.org – COVID-Recovered Immunity is Durable

1.

One-year sustained cellular and humoral immunities of COVID-19 convalescents, Jie Zhang, Hao Lin, Beiwei Ye, Min Zhao, Jianbo Zhan, et al.

SARS-CoV-2-specific IgG antibodies, and also NAb can persist among over 95% COVID-19 convalescents from 6 months to 12 months after disease onset. At least 19/71 (26%) of COVID-19 convalescents (double positive in ELISA and MCLIA) had detectable circulating IgM antibody against SARS-CoV-2 at 12m post-disease onset. Notably, the percentages of convalescents with positive SARS-CoV-2-specific T-cell responses (at least one of the SARS-CoV-2 antigen S1, S2, M and N protein) were 71/76 (93%) and 67/73 (92%) at 6m and 12m, respectively. Furthermore, both antibody and T-cell memory levels of the convalescents were positively associated with their disease severity.

Read full study

This study suggest Covid-19 infected people are at significantly reduced risks of being the source of what are called break out infections with the delta variant.

2.

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections, Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon.

Results SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.

Read Full Study

In this study, 1359 previously Covid-19 infected employees of a large company recorded no re-infection over the course of the study, 5 months.

3.

Necessity of COVID-19 vaccination in previously infected individuals, Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, Paul Terpeluk, Steven M. Gordon

Results Among the 52238 included employees, 1359 (53%) of 2579 previously infected subjects remained unvaccinated, compared with 22777 (41%) of 49659 not previously infected. The cumulative incidence of SARS-CoV-2 infection remained almost zero among previously infected unvaccinated subjects, previously infected subjects who were vaccinated, and previously uninfected subjects who were vaccinated, compared with a steady increase in cumulative incidence among previously uninfected subjects who remained unvaccinated. Not one of the 1359 previously infected subjects who remained unvaccinated had a SARS-CoV-2 infection over the duration of the study. In a Cox proportional hazards regression model, after adjusting for the phase of the epidemic, vaccination was associated with a significantly lower risk of SARS-CoV-2 infection among those not previously infected (HR 0.031, 95% CI 0.015 to 0.061) but not among those previously infected (HR 0.313, 95% CI 0 to Infinity).

Conclusions Individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination, and vaccines can be safely prioritized to those who have not been infected before.

Read Full Study

Researchers funded by COVID supplements from the National Institute of Allergy and Infectious Diseases and the Office of the Director of the National Institutes of Health have conducted longterm studies on Covid-19 patients that suggest the best longterm strategies for dealing with Covid-19 might be in developing herd immunity after all.

4.

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Kristen W. Cohen, Susanne L. Linderman, Zoe Moodie, Julie Czartoski, Lilin Lai, Grace Mantus, Carson Norwood, Lindsay E. Nyhoff, Venkata Viswanadh Edara, et al.

Ending the COVID-19 pandemic will require long-lived immunity to SARS-CoV-2. We evaluated 254 COVID-19 patients longitudinally from early infection and for eight months thereafter and found a predominant broad-based immune memory response. SARS-CoV-2 spike binding and neutralizing antibodies exhibited a bi-phasic decay with an extended half-life of >200 days suggesting the generation of longer-lived plasma cells. In addition, there was a sustained IgG+ memory B cell response, which bodes well for a rapid antibody response upon virus re-exposure. Polyfunctional virus-specific CD4+ and CD8+ T cells were also generated and maintained with an estimated half-life of 200 days. Interestingly, the CD4+ T cell response equally targeted several SARS-CoV-2 proteins, whereas the CD8+ T cell response preferentially targeted the nucleoprotein, highlighting the importance of including the nucleoprotein as a potential vaccine antigen. Taken together, these results suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.

More Evidence

Sign the Declaration

Sputnik V Vaccine Meets US, EU Safety Standards, Russia Says

Parker Davis October 4, 2021

Russia negotiates with the United States and the European Union to admit entry to people vaccinated with Sputnik V

From marketresearchtelecast.com
2021-10-03 21:55:22

Excerpt:

As negotiations progress with the World Health Organization (WHO), Russia began a series of dialogues with USA and the nations of the European Union to allow the entry of those vaccinated against Covid-19 with the Sputnik V. “They listened to the arguments; they understand that it is rational ”, assured the Russian Minister of Health, Mikhail Murashko.

The information was confirmed by the Russian official in a series of tweets published on the official Twitter of the development of the Gamaleya Institute, which was accompanied by a photo of the document issued by the Argentine Government for the application against Covid-19. “Mutual recognition of vaccination certificates is the first step towards mutual recognition of vaccines“Said Murashko.

In this regard, the Russian official said he held talks “in Geneva with the United States and others on the recognition of travel certificates” and stressed that “this is the beginning of a constructive dialogue.” …

Read Full Article

DC Effort to Make Coronavirus Tests Free Fails Spectactularly, Here’s How

Parker Davis September 28, 2021

Congress passed a law to cover the cost of coronavirus testing for Americans by saddling insurance companies with the responsibility of paying for the tests themselves. The cost of the test would be determined by the cash value of whatever the onlie cost of the tests were by the provider they were contracting to administer the tests. The result has been a 25 percent increase in the cost of coronavirus tests from last year to this year, 2021.

The next shoe to drop will be the rise in insurance premiums as insurance companies pass on the cost of government’s promise to the very people the government was allegedly serving. To be fair, there will be a significant segment of society that will get access to this, as of right now, essential service for whom free access could be argued to be necessary, but we need not profoundly affect an essential market so signfiicantly with these simplistic solutions to short term problems to meet the needs of those who truly need it.

I won’t offer a solution in this moment, but there are many that don’t involve solutions that turn out to be no solution for the vast majority of people the government promised would get free testing, only to pay for it in the long run after all. That’s not actually a solution at all, is it? I can easily compete with ‘not a solution,’ and I bet many of our readers can as well.

Covid Rapid Test Prices: How a Law Allows Labs to Charge Any Price

From www.nytimes.com
2021-09-26 09:00:14

Excerpt:

At the drugstore, a rapid Covid test usually costs less than $20.

Across the country, over a dozen testing sites owned by the start-up company GS Labs regularly bill $380.

There’s a reason they can. When Congress tried to ensure that Americans wouldn’t have to pay for coronavirus testing, it required insurers to pay certain laboratories whatever “cash price” they listed online for the tests, with no limit on what that might be.

GS Labs’s high prices and growing presence — it has performed a half-million rapid tests since the pandemic’s start, and still runs thousands daily — show how the government’s longstanding reluctance to play a role in health prices has hampered its attempt to protect consumers. As a result, Americans could ultimately pay some of the cost of expensive coronavirus tests in the form of higher insurance premiums.

Read Full Article

Developing Climate-Harsh-Resistant Crops

Parker Davis September 21, 2021

Research collaboration puts climate-resilient crops in sight

From scienceblog.com
2021-09-17 15:02:11
MIT
Excerpt:

But for farmers who make their living by successfully growing plants, and whose crops may nourish hundreds or thousands of people, the devastation of failing flora is that much greater. As climate change is poised to cause increasingly unpredictable weather patterns globally, crops may be subject to more extreme environmental conditions like droughts, fluctuating temperatures, floods, and wildfire.

Climate scientists and food systems researchers worry about the stress climate change may put on crops, and on global food security. In an ambitious interdisciplinary project funded by the Abdul Latif Jameel Water and Food Systems Lab (J-WAFS), David Des Marais, the Gale Assistant Professor in the Department of Civil and Environmental Engineering at MIT, and Caroline Uhler, an associate professor in the MIT Department of Electrical Engineering and Computer Science and the Institute for Data, Systems, and Society, are investigating how plant genes communicate with one another under…

Read Full Article

Covid-19 Boosters Might Not Be Needed, More Scientists Claim

Freedomist Editor September 20, 2021

Plans by the Biden administration to start offering a third round of booster shots for those who took one of the two-shot Covid-vaccines are being cast into further doubt by a growing list of scientists to doubt the efficacy of such a move in light of evidence that a third booster shot might put people more at risk than less.

Scientists continue to say there isn’t enough evidence to support giving COVID-19 boosters to all Americans

From www.marketwatch.com
2021-09-17 10:36:00

Excerpt:

The U.S. is days away from President Joe Biden’s target date to begin rolling out COVID-19 booster shots to Americans even though experts still say there isn’t a scientific case for boosting the entire eligible population.

The Biden administration announced last month that adults vaccinated with the shots developed by BioNTech SE
BNTX,
+4.90%
/Pfizer Inc.
PFE,
-0.67%
and Moderna Inc.
MRNA,
+1.42%
will qualify for a third dose starting Sept. 20 as long as it’s been eight months since they received their first round of shots and U.S. regulators give the ‘OK.’

But the plan has been criticized by medical experts, who say there isn’t enough clinical data demonstrating all Americans vaccinated with the mRNA shots need a booster because they now face a higher risk of severe disease if they do get sick.

Read Full Article

AI Becoming a Necessity to Quality Healthcare

Parker Davis September 16, 2021

The future of healthcare is dependent on securing AI-powered medical devices

From medcitynews.com
2021-09-12 13:02:42

Excerpt:

Investments in artificial intelligence and machine learning are finally on the rise in healthcare.

While the industry has been slow to adopt AI in comparison to other sectors like financial services and manufacturing – with 70% of health systems yet to establish a formal program – a recent survey found that 68% of health system executives plan to invest more in AI in the next five years to help reach their strategic goals. And the investments are expected to be significant; the global AI in healthcare market size is estimated to reach $120.2 billion by 2028.

The opportunities for AI in healthcare are widespread, spanning both operational and clinical use cases including fraud prevention, voice-assisted charting, registration, remote patient monitoring and more. AI holds particular promise for connected medical devices and telehealth – an integral part of the Internet of Medical Things (IoMT) – as it enables faster triage, intake, detection and decision making.

In fact, new patient apps and connected medical devices leveraging AI are already being launched regularly. For example, Google recently introduced a new AI-powered dermatology app that uses image recognition algorithms to provide expert, personalized help by suggesting possible skin conditions based on patient-uploaded photos. A Philips device leverages insights from AI to diagnose and treat oncology patients. And Amwell’s new telehealth platform enables providers to receive alerts on their patients’ health status via an AI-powered, automated real-time early warning score system.

While there is significant potential for AI in healthcare, there are also limitations. The primary challenge that has not yet been widely discussed, however, is how best to secure AI-powered connected medical devices from increasingly frequent and complex cybersecurity risks.

Securing the IoMT in the age of AI is imperative

While AI can and often has been used for good, it can also be used to discover and exploit…